As 2026 unfolds, the landscape of cardiovascular medication safety is shifting under the weight of new FDA recalls and updated prescribing information. From carcinogenic impurities in losartan to ...

If you or someone you love takes medication to treat high blood pressure (hypertension), chances are you've heard of losartan. It's one of the most commonly prescribed blood pressure medications in ...

The FDA has announced two added recalls of blood pressure medication tainted with a cancer-causing impurity. Legacy Pharmaceutical Packaging, LLC issued a voluntary nationwide recall of Losartan ...

Patients with glioblastoma - the deadliest type of primary brain tumor - may potentially benefit from immunotherapy medications called immune checkpoint inhibitors that stimulate an immune response ...

New research has shown the drug losartan, normally used to treat high blood pressure (hypertension), is not effective in slowing down the progression of Alzheimer's disease (AD) in people with mild-to ...

Several clinical trials have demonstrated the relative tolerability of losartan. [8,14,18,19,20] The most frequent adverse reaction, as observed in a clinical trial of 2900 patients assessing the ...

In a new study, researchers determined that the common blood pressure medication, losartan, is not effective in reducing hospitalization for mildly-ill COVID-19 outpatients. University of Minnesota ...

Scienture Holdings, Inc. (NASDAQ:SCNX) on Tuesday announced that it has formalized a commercial Pharmacy Benefit Manager (PBM) led Group Purchasing Organization (GPO) rebate agreement, advancing the ...

U.S. losartan market totals approximately $241M annually with around 72M prescriptions, creating a significant opportunity for ARBLI™ as the ...

A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan. The recall is due to an "impurity" that is classified as a ...